Deals this week: Takeda Pharmaceutical, HUYA Bioscience International, Egalet

Japanese pharmaceutical company Takeda Pharmaceutical has signed a global agreement with US-based bio-pharmaceutical company Ovid Therapeutics for clinical development and commercialisation of the former ’s investigational new drug TAK-935.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news